Search

everythinglearnresearchcommunity

for

Search:↓

Effective treatment for skin issues in women with PCOS includes oral contraceptives, antiandrogens, and other medications and procedures.

Hirsutism in women often indicates health issues like polycystic ovarian syndrome and is treated with lifestyle changes, medication, and cosmetic measures.

Using GnRHa agonists helps diagnose and treat ovarian hyperthecosis when surgery isn't possible.

Monitoring for adverse effects in clinical treatments is crucial.

Castration is preferred for non-breeding male dogs with BPH, but other treatments are available with specific pros and cons.

The combination therapy reduced hirsutism in women with PCOD and was well-tolerated.

The research found that polycystic ovary syndrome (PCOS) has two distinct types, with one having more severe hormone and insulin issues.

The conclusion is that lifestyle changes and weight loss are first-line treatments for infertility due to anovulation, with various medications and assisted reproductive technologies as additional options.

Some antiandrogens may lower testosterone better than others, but it's unclear which is best for feminization in transgender women; more research is needed.

Hormones control reproduction and are crucial for body balance.

The conclusion is that removing both ovaries is the best treatment for excess male hormones in postmenopausal women, with medication as another option, and managing insulin resistance is important for diagnosis and treatment.

Hirsutism in women often indicates a hormonal imbalance and can be managed with a combination of hormonal treatments and hair removal methods.

The document concludes that correct diagnosis and management of PCOS are important, and more research is needed on its risks and treatments.

The document concludes that treating androgen excess needs patience, managing expectations is important, and many drugs used are not officially approved, suggesting cosmetic options for mild cases.

Early medical support for transgender youth is important for their health, with low regret for gender-affirming hormone use and a need for knowledgeable care providers.

Treating early puberty with hormone therapy may increase the risk of polycystic ovary syndrome in adults.

The document concludes that a systematic approach is crucial to identify causes of androgen excess in women beyond the most common cause, Polycystic ovary syndrome (PCOS).

GnRH analogues are effective for diagnosing and treating female androgen excess, offering a non-surgical option.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

Cyproterone acetate is the preferred treatment for women's hyperandrogenism when estrogen/progestogen use is safe.

A postmenopausal woman's excess male hormone symptoms improved after her ovaries were removed.

Removing both ovaries may better treat increased male hormone levels and related symptoms in postmenopausal women when hormone therapy doesn't work.

GnRH analogue can help diagnose ovarian causes of high testosterone in postmenopausal women when scans don't show the cause.

Non-binary transgender individuals need personalized hormonal treatments for better well-being and quality of life.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

Antiandrogens can help treat skin conditions like acne and excessive hair in women when used carefully.

Treating hirsutism in women often requires a mix of medications and cosmetic methods for best results.

Testosterone treatment effectively causes male physical development in transgender male adolescents but may lead to side effects like acne, higher BMI and blood pressure, lower good cholesterol, and decreased bone density.

The document concludes that various cosmetic and drug treatments are available for hirsutism, and some new drugs show promise.

Ovarian stromal hyperplasia can cause high testosterone in postmenopausal women and is treated by removing the ovaries.